Refine
Has Fulltext
- yes (41)
Year of publication
Document Type
- Journal article (39)
- Book (2)
Language
- English (41)
Keywords
- Fabry disease (4)
- consortium (4)
- genetic modifiers (3)
- investigators (3)
- Box-Jenkins-Verfahren (2)
- Box–Jenkins Program (2)
- Fabry nephropathy (2)
- Frequency Domain (2)
- SAS <Programm> (2)
- State-Space Models (2)
- Time Series Analysis (2)
- Zeitreihenanalyse (2)
- Zustandsraummodelle (2)
- anxiety (2)
- cardiomyopathy (2)
- chronic kidney disease (2)
- common variants (2)
- education (2)
- genome-wide association (2)
- hypertrophic cardiomyopathy (2)
- ischemic stroke (2)
- modifiers (2)
- ovarian cancer (2)
- prospective (2)
- radiotherapy (2)
- single-nucleotide polymorphisms (2)
- survival (2)
- susceptibility loci (2)
- A-delta fibers (1)
- ALS treatment (1)
- Alpha-Galactosidase (1)
- Alzheimer’s disease (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Anderson-Fabry Disease (1)
- BRCA1/2 (1)
- CRISPR-Cas Systems (1)
- CXCL10 (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cimex lectularius (1)
- D313Y genotype (1)
- DNA (1)
- DNA damage (1)
- DNA double strand breaks (1)
- DNA methylation (1)
- Enzyme replacement therapy (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- Fabry cardiomyopathy (1)
- Fabry patient (1)
- Fabry-associated pain (1)
- Galactosidase-A gene (1)
- Genotype–phenotype correlations (1)
- Heart failure (1)
- Histologic grade (1)
- IFNG (1)
- Induced Pluripotent Stem Cells (1)
- K-region (1)
- Kidney function (1)
- LV mass (1)
- Lag time (1)
- MTB (1)
- Male breast cancer (1)
- NEIL2 (1)
- Natural-history data (1)
- OGG1 (1)
- Outcome survey (1)
- Ovarian (1)
- Pain (1)
- Pain-related evoked potentials (1)
- Pathology (1)
- QuantiFERON\(^®\)-TB Gold Plus (1)
- RESP model (1)
- RT-qPCR (1)
- Racial differences (1)
- STS (1)
- Small fiber neuropathy (1)
- Stroke (1)
- T-Track\(^®\) TB (1)
- TB (1)
- Troponin (1)
- VEMP (1)
- ZNF365 (1)
- [18F]FDG-PET-CT (1)
- \(\gamma\)h2ax (1)
- abdominal lymph node metastases (1)
- accuracy (1)
- active TB (1)
- alleles (1)
- alpha/delta agonist GFT505 (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anticoagulation (1)
- assistive devices (1)
- astrogliosis (1)
- atherogenic dyslipidaemia (1)
- atrial fibrillation (1)
- bed bug (1)
- biomarkers (1)
- biosynthesis (1)
- blended learning (1)
- blood lymphocytes (1)
- breast cancer (1)
- bridging (1)
- brucei (1)
- cadherins (1)
- cancer (1)
- cancer care (1)
- candidate genes (1)
- cardiac dysfunction (1)
- cardiac hypertrophy (1)
- cardiac rehabilitation (1)
- cardiogenetics (1)
- cardiovascular munster procam (1)
- caregiver burden (1)
- cell (1)
- cerebral ischemia (1)
- chemistry (1)
- chemotherapy (1)
- chip-seq (1)
- clinical skills (1)
- cornea verticillata (1)
- coronary artery disease (1)
- crithidia fasciulata (1)
- cryptogenic stroke (1)
- damage (1)
- decreasing autonomy (1)
- depression (1)
- diabetic mouse (1)
- e-Learning (1)
- echocardiography (1)
- ejection fraction (1)
- elements (1)
- enzyme replacement therapy (1)
- epigenetics (1)
- exercise training (1)
- expression signature (1)
- extinction (1)
- feasibility (1)
- female (1)
- foci (1)
- frailty (1)
- functional status (1)
- gender (1)
- genetic interaction networks (1)
- genetic variants (1)
- genetics (1)
- genome (1)
- haplogroups (1)
- health-related quality of life (1)
- health-related quality of life (HRQoL) (1)
- hearing loss (1)
- heart failure (1)
- heterozygote (1)
- high denisty lipoprotein (1)
- histone H2AX (1)
- home-based-rehabilitation (1)
- hormone-related protein (1)
- human ectoparasite (1)
- humans (1)
- immune check inhibitor (1)
- in vivo (1)
- in vivo imaging (1)
- individual radiosensitivity (1)
- infection detection (1)
- informal caregiving (1)
- inherited metabolic disorders (1)
- left ventricular mass (1)
- leishmaniasis (1)
- low-molecular heparin (1)
- luminescence (1)
- lymph node (1)
- lysosomal storage disorder (1)
- mRNA (1)
- mammographic density (1)
- medical device training (1)
- mesoscopics (1)
- metabolism (1)
- middle aged (1)
- migration (1)
- mitochondria (1)
- molecular diagnostics (1)
- monoamine oxidase A (1)
- multicentric (1)
- multiple diseases (1)
- neck cancer (1)
- neurodevelopmental disorders / genetics (1)
- neuroprotection (1)
- neurorepair (1)
- nitrate and thyroid carcinogenesis (1)
- non-interventional (1)
- old patients (1)
- oral mucositis (1)
- oral squamous cell carcinoma (1)
- oropharyngeal carcinoma (1)
- orylation (1)
- outcomes research (1)
- outreach (1)
- oxidative stress (1)
- pN1 (1)
- parathyroid carcinoma (1)
- patient access (1)
- pediatric thyroid cancer after Chernobyl and Fukushima (1)
- pembrolizumab (1)
- phospholipid fatty acids (1)
- phosphorylation (1)
- physical activity (1)
- placebo-controlled trial (1)
- point-of-care echocardiography (1)
- polycyclic aromatic hydrocarbons (1)
- polymorphism (1)
- population (1)
- postoperative bleeding (1)
- precision oncology (1)
- progression-free survival (1)
- psychological interventions (1)
- psychological support (1)
- purification (1)
- quality of life (1)
- quality of life (QoL) (1)
- radiosensitivity (1)
- randomized controlled-trial (1)
- real world data (1)
- rectal cancer (1)
- redox (1)
- renal dysfunction (1)
- renal fibrosis (1)
- repair (1)
- repeated surgery (1)
- resection (1)
- residual cardiovascular risk (1)
- rising incidence of thyroid cancer (1)
- sarcoma (1)
- scientific guidelines (1)
- screening and overdiagnosis (1)
- secondary prevention (1)
- selection (1)
- septal hypertrophy (1)
- small vessel disease (1)
- socioeconomic status (1)
- stroke unit (1)
- subtypes (1)
- superconductivity (1)
- surgery (1)
- susceptibility (1)
- susceptibility alleles (1)
- symptom-specific treatment (1)
- system (1)
- systolic dysfunction (1)
- targeted gene panel (1)
- tele-medicine (1)
- term fenofibrate therapy (1)
- therapeutic options (1)
- thromboembolism (1)
- topological insulators (1)
- trabectedin (1)
- translational research (1)
- triglyceride-rich lipoproteins (1)
- troponin (1)
- trypanosoma cruzi (1)
- tuberculosis (1)
- tumor subtypes (1)
- type 2 diabetes (1)
- type-2 diabetes mellitus (1)
- urinary protein excretion (1)
- variants (1)
- vascular dementia (1)
- vertigo (1)
- whole exome sequencing (1)
- young patients (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Medizinische Klinik und Poliklinik I (11)
- Institut für Humangenetik (9)
- Neurologische Klinik und Poliklinik (7)
- Institut für Klinische Epidemiologie und Biometrie (4)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Medizinische Klinik und Poliklinik II (3)
- Institut für Mathematik (2)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Klinik und Poliklinik für Nuklearmedizin (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Pathologisches Institut (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Comprehensive Cancer Center Mainfranken (1)
- Institut Mensch - Computer - Medien (1)
- Institut für Anorganische Chemie (1)
- Institut für Organische Chemie (1)
- Institut für Psychologie (1)
- Institut für Psychotherapie und Medizinische Psychologie (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (1)
- Klinik und Poliklinik für Strahlentherapie (1)
- Physikalisches Institut (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
- Urologische Klinik und Poliklinik (1)
Sonstige beteiligte Institutionen
(1) Background: Evaluation of impact of adjuvant radiation therapy (RT) in patients with oral squamous cell carcinoma of the oral cavity/oropharynx (OSCC) of up to 4 cm (pT1/pT2) and solitary ipsilateral lymph node metastasis (pN1). A non-irradiated group with clinical follow-up was chosen for control, and survival and quality of life (QL) were compared; (2) Methods: This prospective multicentric comprehensive cohort study included patients with resected OSCC (pT1/pT2, pN1, and cM0) who were allocated into adjuvant radiation therapy (RT) or observation. The primary endpoint was overall survival. Secondary endpoints were progression-free survival and QL after surgery; (3) Results: Out of 27 centers, 209 patients were enrolled with a median follow-up of 3.4 years. An amount of 137 patients were in the observation arm, and 72 received adjuvant irradiation. Overall survival did not differ between groups (hazard ratio (HR) 0.98 [0.55–1.73], p = 0.94). There were fewer neck metastases (HR 0.34 [0.15–0.77]; p = 0.01), as well as fewer local recurrences (HR 0.41 [0.19–0.89]; p = 0.02) under adjuvant RT. For QL, irradiated patients showed higher values for the symptom scale pain after 0.5, two, and three years (all p < 0.05). After six months and three years, irradiated patients reported higher symptom burdens (impaired swallowing, speech, as well as teeth-related problems (all p < 0.05)). Patients in the RT group had significantly more problems with mouth opening after six months, one, and two years (p < 0.05); (4) Conclusions: Adjuvant RT in patients with early SCC of the oral cavity and oropharynx does not seem to influence overall survival, but it positively affects progression-free survival. However, irradiated patients report a significantly decreased QL up to three years after therapy compared to the observation group.